A new study explores the role of dysfunctioning mitochondria and a disrupted gut microbiome as a possible trigger of Crohn's ...

A new study in mice suggests that dysfunctional mitochondria may change the gut microbiome and thus drive Crohn's disease.

A diet high in ultraprocessed foods can raise the relapse risk in patients with Crohn’s disease who are in remission, with ...

This is Chapter 1 in the Wellness Memoir. Come back every Friday for the next two months to walk this journey with Jaimi, one ...

Researchers at the Technical University of Munich (TUM) have linked mitochondrial dysfunctions to Crohn’s disease, ...

On a mission to collect a key Crohn’s disease approval and build out its inflammatory bowel disease (IBD) profile, Eli Lilly ...

Today, there is an alarming trend in diagnoses of Crohn's Disease in Black populations? Here is why and what you need to ...

Researchers at UC San Diego believe they have identified the next step in advancing our understanding of Crohn’s disease, a ...

At 52 weeks of follow-up, more patients on Eli Lilly’s monoclonal antibody Omvoh demonstrated histologic response, suggesting ...

Eli Lilly and Company (NYSE: LLY) announced data demonstrating more patients with moderately to severely active Crohn's ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...